Favourable effect of transcutaneous vagus nerve stimulation on health-related quality of life in patients with heart failure and moderately reduced or preserved ejection fraction
The impact of modulation of SNS activity on the evolution of heart failure and exercise capacity in patients with resistant hypertension and heart failure with preserved ejection fraction
Characteristics of participants derived from direct-to-consumer vs. clinical referrals in the baroreflex activation therapy for heart failure (BeAT-HF) trial